Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. - Wikidata - awgldk - TriplyDB

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

http://www.wikidata.org/entity/Q37733586

about

Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN Complement cascade and kidney transplantation: The rediscovery of an ancient enemy High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies.Complement involvement in kidney diseases: From physiopathology to therapeutical targeting Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.Complement related kidney diseases: Recurrence after transplantation.Histopathology of MPGN and C3 glomerulopathies.Primary disease recurrence—effects on paediatric renal transplantation outcomes.Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Current status of pediatric renal transplant pathology.Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.C3 glomerulopathy.Update on C3 glomerulopathy.De novo C3 glomerulonephritis in a renal allograft.Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis.De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?Recurrence of primary glomerulonephritis: Review of the current evidence.Recurrence of primary glomerulonephritis: Review of the current evidence.The role of complement inhibition in kidney transplantation.Treating C3 glomerulopathy with eculizumab.C3 Glomerulopathy.Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseases

P2860

Q26741542-66BF8404-E1D1-4F71-A3AC-4B4834E4B041 Q26829790-01748541-E40C-4349-A934-B59B92C84A4E Q33425245-FB57B8A7-64CA-4AE0-901D-ACE31F4E7EC8 Q35567841-9DFDF029-8B45-4984-BAE8-31E9EF2ADBCC Q35891170-26242252-7BA0-4AF1-BD6F-EC515E6FC01E Q37522557-92F8DF1B-8B3D-407E-A619-DD23FF36904B Q38275117-5A5323C6-BA5E-42EC-AF78-8BAB349DCA58 Q38445275-0290F6D7-D9D1-4338-A564-10D6F080C791 Q38549182-F1B22CB3-EE56-49A6-AB52-09F0E92E21D9 Q38749694-71766696-9931-420D-9E5F-01E085997E78 Q38843499-77862C1A-8466-4FF0-8550-6C24B6A65C52 Q38880897-01373FAB-FBA5-4924-96EA-1714D38A8F7B Q38896793-185EC673-1072-4770-9DEC-241689096856 Q39207807-F5A99319-F257-4476-BB50-DD1C462F7D0F Q40744602-D18C2B81-CE7F-484E-A582-0EF046CC1560 Q40751722-AF0CDEE2-52F5-41A5-B92E-E6C2302C5DB3 Q42392710-223D98D8-2719-4EFE-A48D-E2460AC86782 Q47172094-7847E906-DF3F-43D9-847E-F990D6D477C7 Q47193282-D346BAD1-5A51-4142-93F2-E605CB1F54F1 Q47243136-1F6FD689-0CB6-45E9-B6AE-01185A5F1AA7 Q47720351-28B55C01-CC79-436C-909C-0FF8624FA9D4 Q48252388-32C799C4-7BA1-484E-BCAA-82C65DAF5E71 Q52876323-F3146DC1-AAD2-4723-A165-027524266263 Q55450113-63F04110-8C5B-4B3A-B124-93178E37A88D Q58120548-567AB359-331E-4326-A1E0-037C7A097B1E

P2860

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

http://www.wikidata.org/entity/Q37733586

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@en

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@nl

type

label

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@en

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@nl

prefLabel

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@en

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@nl

P1433

Q37733586-11FB9EF8-0D91-42E6-97C8-1958ADA8DA88

P1476

Q37733586-9FAB21D2-DEB4-47C8-A804-E0EECED6393D

P2093

Q37733586-0900881C-5738-46A9-B4A9-AF1D10DD2CB8

Q37733586-1EFE7B7F-E104-4F06-A34B-8AF2AA28A6D4

Q37733586-66379A3C-1472-45C1-9121-6395D291E857

Q37733586-85897C65-ABCF-4488-A9F7-269CE229469D

Q37733586-E96204DF-2382-4F6F-9492-39B5ADCE35D1

Q37733586-EA2C6C48-3EBA-423E-B121-8B70C979060B

Q37733586-F85AC3FA-EBC4-46C0-8344-296FE5766C7C

P2860

Q37733586-0423ACA3-CD36-4F62-8A75-3C8E432E5582

Q37733586-170FD370-DAD7-444E-92E8-29BC627B4427

Q37733586-1ACECF2F-4424-403E-B23C-4F15C6DF89F4

Q37733586-22BF4F0D-8DF2-497E-B465-59648A5ADD8B

Q37733586-29763DB8-94EC-410E-AB64-B36DAE9D922A

Q37733586-70B160A1-2440-4202-ADB5-49E227B3E769

Q37733586-85FB6B4F-5420-4230-B576-E0B9CA0AC713

Q37733586-87F4F1A1-61D3-408E-A647-DFBC7A96A6E4

Q37733586-88F35D40-2807-4AFD-9D75-D9BDE6D38835

Q37733586-8FB49EAB-C12E-45AC-A473-849231EB0529

P304

Q37733586-625587D5-F7A8-4495-A0C9-CF0ACCBE5823

P31

Q37733586-3D666C64-E273-4F00-B335-EC1948E61A9E

P356

Q37733586-2B33CF62-F232-41A9-B336-C7EC7A0C3B12

P433

Q37733586-E75E7065-D864-407C-8C87-6AFEBD9083D5

P478

Q37733586-8D5799E3-7B80-42E3-88B0-ADCC987245F0

P50

Q37733586-87AEF007-9652-46D6-A051-12CD294A542D

P577

Q37733586-3129F718-9837-42DE-AA92-A1EB0592069E

P698

Q37733586-44CE78E6-0254-4729-8180-3C3FEF8C7B4C

P921

Q37733586-e8eb0c62-4544-43fc-8e05-ad3a6e72aa11

P932

Q37733586-54780656-304A-4C4F-AA37-E830079F7E21

P356

P1433

Journal of the American Society of Nephrology

P1476

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.

@en

P2093

Elizabeth C Lorenz

http://www.w3.org/2001/XMLSchema#string

Fernando C Fervenza

http://www.w3.org/2001/XMLSchema#string

Fernando G Cosio

http://www.w3.org/2001/XMLSchema#string

Ladan Zand

http://www.w3.org/2001/XMLSchema#string

Manish J Gandhi

http://www.w3.org/2001/XMLSchema#string

Samih H Nasr

http://www.w3.org/2001/XMLSchema#string

Sanjeev Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

Membranoproliferative glomerulonephritis--a new look at an old entity

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.

Eculizumab and recurrent C3 glomerulonephritis

C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.

P304

1110-1117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013070715

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Richard J Smith

P577

2013-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24357668

http://www.w3.org/2001/XMLSchema#string

P921

P932

4005307

http://www.w3.org/2001/XMLSchema#string